Curateq Biologics
Overview
<p>CuraTeQ Biologics (a wholly owned subsidiary of Aurobindo Pharma Ltd.) is a biopharmaceutical company based out of Hyderabad, India. Our vision is to improve the wellbeing of patients suffering from debilitating illnesses by providing them access to high quality and cost-effective biosimilars.</p><p>CuraTeQ has a development pipeline of 14 biosimilars, of which, three products have been filed with EMA, one product has been filed with MHRA, and four more products are in global phase 3 clinical trials.</p><p>Our Mission:<br>● Deliver exceptional value to stakeholders and better health outcomes to patients by becoming a leading global biosimilars developer by 2030.<br>● Build deep capabilities in development and manufacturing to deliver quality and cost-effective biosimilars for patients across the globe.<br>● Create a sustainable and broad portfolio of biosimilars with a focus on oncology and immunology therapies.</p>
About Us
<p>CuraTeQ Biologics (a wholly owned subsidiary of Aurobindo Pharma Ltd.) is a biopharmaceutical company based out of Hyderabad, India. Our vision is to improve the wellbeing of patients suffering from debilitating illnesses by providing them access to high quality and cost-effective biosimilars.</p><p>CuraTeQ has a development pipeline of 14 biosimilars, of which, three products have been filed with EMA, one product has been filed with MHRA, and four more products are in global phase 3 clinical trials.</p><p>Our Mission:<br>● Deliver exceptional value to stakeholders and better health outcomes to patients by becoming a leading global biosimilars developer by 2030.<br>● Build deep capabilities in development and manufacturing to deliver quality and cost-effective biosimilars for patients across the globe.<br>● Create a sustainable and broad portfolio of biosimilars with a focus on oncology and immunology therapies.</p>
Headquarters
Hyderabad / Secunderabad, Telangana